Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. Bloomberg's Neil Campling has the details. (Source: Bloomberg)
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. Bloomberg's Neil Campling has the details. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/d4e4b18c0988fae945e3aee859f77e10978c571b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Isomorphic Labs Seeks Funding at Valuation of $40 Billion"></iframe>
